GlassScriptPhysician profile
Alexis Chesrow
NPI 1427207281
$17,237.36
in general payments reported to CMS, 2019-2025
33 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $8,022 · 2021: $2,109 · 2022: $600 · 2023: $3,252 · 2024: $2,167 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,334 · Travel and Lodging: $1,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,333.83 |
| Travel and Lodging | $1,840.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,707.15 | 2019-2020 | |
| Coloplast Corp | $2,539.62 | 2020-2025 | Altis, Titan, Saffron |
| Medtronic, INC. | $2,097.96 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $1,258.42 | 2019-2025 | Upsylon, Ams 700, Advantage System |
| Axonics, INC. | $1,220.53 | 2021-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $347.02 | 2019-2024 | Xtandi |
| Medtronic USA, INC. | $335.07 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $250.94 | 2021-2023 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $171.28 | 2023 | Aquabeam Robotic System |
| Urogen Pharma, INC. | $166.87 | 2023-2025 | Jelmyto |
| Bluewind Medical | $159.29 | 2024 | Revi |
| Cycle Pharmaceuticals INC | $122.37 | 2025 | Venxxiva |
| Teleflex LLC | $104.44 | 2021-2022 | |
| Myovant Sciences INC. | $91.20 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $87.45 | 2023 | Pylarify |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $84.65 | 2020-2025 | |
| Koelis INC. | $78.95 | 2024 | |
| Karl Storz Endoscopy-America | $64.56 | 2023 | Flex-X |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Urovant Sciences INC | $49.60 | 2021-2022 | |
| Endo USA, INC. | $45.93 | 2024-2025 | Xiaflex, Aveed |
| Abbvie INC. | $37.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $25.01 | 2023 | Lynparza |
| Dendreon Pharmaceuticals LLC | $20.08 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.59 | 2024 | Jynarque |
| Caldera Medical, INC | $17.94 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.46 | 2022 | |
| Abc Home Medical Supply, INC. | $16.95 | 2023 | |
| Mission Pharmacal Company | $13.17 | 2022 | |
| Smith+Nephew, INC. | $12.68 | 2019 | |
| Pfizer INC. | $12.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.97 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Chesrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.